e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disease progression in young patients with COPD: rethinking the Fletcher and Peto model
Sanchez-Salcedo Pablo, Divo Miguel, Casanova Ciro, Pinto-Plata Victor, de-Torres Juan P., Cote Claudia, Cabrera Carlos, Zagaceta Jorge, Rodriguez-Roisin Roberto, Zulueta Javier J., Marin Jose Maria, Celli Bartolome
Source:
Eur Respir J 2014; 44: 324-331
Journal Issue:
August
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sanchez-Salcedo Pablo, Divo Miguel, Casanova Ciro, Pinto-Plata Victor, de-Torres Juan P., Cote Claudia, Cabrera Carlos, Zagaceta Jorge, Rodriguez-Roisin Roberto, Zulueta Javier J., Marin Jose Maria, Celli Bartolome. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J 2014; 44: 324-331
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The natural history of COPD: confirming and going beyond Fletcher and Peto
Source: Eur Respir J 2014; 44: 280-283
Year: 2014
Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients – nationwide data from Denmark
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
COPD: CardiOPulmonary Disease?
Source: Eur Respir J 2013; 41: 1241-1243
Year: 2013
Disease severity in COPD patients
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Disease progression patterns in COPD
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Investigation of sarcopenia in Japanese COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013
Disease specific knowledge in Tunisian COPD patients
Source: International Congress 2018 – COPD around the world
Year: 2018
GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept